Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Phospho-mTOR expression in human glioblastoma microglia-macrophage cells.

Lisi L, Ciotti GMP, Chiavari M, Pizzoferrato M, Mangiola A, Kalinin S, Feinstein DL, Navarra P.

Neurochem Int. 2019 Jun 10;129:104485. doi: 10.1016/j.neuint.2019.104485. [Epub ahead of print]

2.

Effects of the CRMP2 activator lanthionine ketimine ethyl ester on oligodendrocyte progenitor cells.

Savchenko V, Kalinin S, Boullerne AI, Kowal K, Lin SX, Feinstein DL.

J Neuroimmunol. 2019 Jun 3;334:576977. doi: 10.1016/j.jneuroim.2019.576977. [Epub ahead of print]

PMID:
31177034
3.

Adherence to Long-Term Follow-Up of Patients with Life-Threatening, Inhaled Synthetic Cannabinoids-Associated Coagulopathy in Chicago.

Tole M, LaBedz S, Feinstein DL, Rubinstein I.

Lung. 2019 Jun;197(3):349-352. doi: 10.1007/s00408-019-00227-2. Epub 2019 Apr 19.

PMID:
31004190
4.

The relative toxicity of brodifacoum enantiomers.

Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G, Rubinstein I.

Toxicol Lett. 2019 May 15;306:61-65. doi: 10.1016/j.toxlet.2019.02.011. Epub 2019 Feb 16.

PMID:
30779948
5.

Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?

Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.

Drugs R D. 2019 Mar;19(1):67-71. doi: 10.1007/s40268-019-0261-4.

6.

Comment on: Pesticide-Poisoned Patients: Can They Be Used as Potential Organ Donors?

Rubinstein I, Feinstein DL.

J Med Toxicol. 2018 Dec;14(4):331-332. doi: 10.1007/s13181-018-0682-4. Epub 2018 Oct 1. No abstract available.

PMID:
30276621
7.

Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.

Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.

Rapid Commun Mass Spectrom. 2018 Nov 30;32(22):1941-1948. doi: 10.1002/rcm.8263.

PMID:
30117207
8.

The Bile Sequestrant Cholestyramine Increases Survival in a Rabbit Model of Brodifacoum Poisoning.

Lindeblad M, Lyubimov A, van Breemen R, Gierszal K, Weinberg G, Rubinstein I, Feinstein DL.

Toxicol Sci. 2018 Oct 1;165(2):389-395. doi: 10.1093/toxsci/kfy147.

9.

Influence of diet on axonal damage in the EAE mouse model of multiple sclerosis.

Dupree JL, Feinstein DL.

J Neuroimmunol. 2018 Sep 15;322:9-14. doi: 10.1016/j.jneuroim.2018.05.010. Epub 2018 May 20.

PMID:
29803554
10.

Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis.

Kalinin S, González-Prieto M, Scheiblich H, Lisi L, Kusumo H, Heneka MT, Madrigal JLM, Pandey SC, Feinstein DL.

J Neuroinflammation. 2018 May 14;15(1):141. doi: 10.1186/s12974-018-1184-7.

11.

CCL2 Induces the Production of β2 Adrenergic Receptors and Modifies Astrocytic Responses to Noradrenaline.

Gutiérrez IL, González-Prieto M, García-Bueno B, Caso JR, Feinstein DL, Madrigal JLM.

Mol Neurobiol. 2018 Oct;55(10):7872-7885. doi: 10.1007/s12035-018-0960-9. Epub 2018 Feb 24.

PMID:
29478130
12.

Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring?

Rubinstein I, Weinberg G, van Breemen R, Hershow RC, Feinstein DL.

Toxicol Commun. 2018;2(1):59-61. doi: 10.1080/24734306.2018.1500152. Epub 2018 Aug 13.

PMID:
30923779
13.

The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.

Braun D, Feinstein DL.

Brain Res. 2019 Jan 1;1702:29-37. doi: 10.1016/j.brainres.2017.12.028. Epub 2017 Dec 21.

PMID:
29274883
14.

Neuroprotective and neurotrophic effects of Lanthionine Ketimine Ester.

Marangoni N, Kowal K, Deliu Z, Hensley K, Feinstein DL.

Neurosci Lett. 2018 Jan 18;664:28-33. doi: 10.1016/j.neulet.2017.11.018. Epub 2017 Nov 8.

PMID:
29128626
15.

The Long-Lasting Rodenticide Brodifacoum Induces Neuropathology in Adult Male Rats.

Kalinin S, Marangoni N, Kowal K, Dey A, Lis K, Brodsky S, van Breemen R, Hauck Z, Ripper R, Rubinstein I, Weinberg G, Feinstein DL.

Toxicol Sci. 2017 Sep 1;159(1):224-237. doi: 10.1093/toxsci/kfx134.

16.

The Severity of Intracranial Hemorrhages Measured by Free Hemoglobin in the Brain Depends on the Anticoagulant Class: Experimental Data.

Ware KM, Feinstein DL, Rubinstein I, Battula P, Otero J, Hebert L, Wang TF, Ivanova A, Chaudhary S, Hemminger J, Brodsky SV.

Stroke Res Treat. 2017;2017:6516401. doi: 10.1155/2017/6516401. Epub 2017 Jul 20.

17.

Heparanase: Potential roles in multiple sclerosis.

Changyaleket B, Deliu Z, Chignalia AZ, Feinstein DL.

J Neuroimmunol. 2017 Sep 15;310:72-81. doi: 10.1016/j.jneuroim.2017.07.001. Epub 2017 Jul 5. Review.

PMID:
28778449
18.

Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.

Braun DJ, Kalinin S, Feinstein DL.

ASN Neuro. 2017 Mar-Apr;9(2):1759091417696161. doi: 10.1177/1759091417696161.

19.

Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.

Lisi L, Ciotti GM, Braun D, Kalinin S, Currò D, Dello Russo C, Coli A, Mangiola A, Anile C, Feinstein DL, Navarra P.

Neurosci Lett. 2017 Apr 3;645:106-112. doi: 10.1016/j.neulet.2017.02.076. Epub 2017 Mar 2.

PMID:
28259657
20.

Brodifacoum poisoning: A clear and present danger to public health in the USA.

Feinstein DL, Brodsky S, Weinberg G, van Breeman R, Rubinstein I.

Toxicol Lett. 2017 Feb 15;268:71-72. doi: 10.1016/j.toxlet.2017.01.004. Epub 2017 Jan 11. No abstract available.

PMID:
28088390
21.

Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.

Feinstein DL, Kalinin S, Braun D.

J Neurochem. 2016 Oct;139 Suppl 2:154-178. doi: 10.1111/jnc.13447. Epub 2016 Mar 10. Review.

22.

Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.

Moyano AL, Li G, Boullerne AI, Feinstein DL, Hartman E, Skias D, Balavanov R, van Breemen RB, Bongarzone ER, Månsson JE, Givogri MI.

J Neurosci Res. 2016 Dec;94(12):1579-1587. doi: 10.1002/jnr.23899. Epub 2016 Aug 25.

PMID:
27557608
23.

Differential effects on glial activation by a direct versus an indirect thrombin inhibitor.

Marangoni MN, Braun D, Situ A, Moyano AL, Kalinin S, Polak P, Givogri MI, Feinstein DL.

J Neuroimmunol. 2016 Aug 15;297:159-68. doi: 10.1016/j.jneuroim.2016.05.018. Epub 2016 May 24.

PMID:
27397090
24.

The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures.

Feinstein DL, Akpa BS, Ayee MA, Boullerne AI, Braun D, Brodsky SV, Gidalevitz D, Hauck Z, Kalinin S, Kowal K, Kuzmenko I, Lis K, Marangoni N, Martynowycz MW, Rubinstein I, van Breemen R, Ware K, Weinberg G.

Ann N Y Acad Sci. 2016 Jun;1374(1):111-22. doi: 10.1111/nyas.13085. Epub 2016 May 31. Review.

25.

Membrane Cholesterol Modulates Superwarfarin Toxicity.

Marangoni MN, Martynowycz MW, Kuzmenko I, Braun D, Polak PE, Weinberg G, Rubinstein I, Gidalevitz D, Feinstein DL.

Biophys J. 2016 Apr 26;110(8):1777-1788. doi: 10.1016/j.bpj.2016.03.004.

26.

Glial cell biology in the Great Lakes region.

Feinstein DL, Skoff RP.

J Neuroinflammation. 2016 Mar 31;13(1):69. doi: 10.1186/s12974-016-0534-6.

27.

LC-MS-MS Analysis of Brodifacoum Isomers in Rat Tissue.

Hauck ZZ, Feinstein DL, van Breemen RB.

J Anal Toxicol. 2016 May;40(4):304-9. doi: 10.1093/jat/bkw008. Epub 2016 Feb 23.

28.

Accountable Care Organizations and Antitrust Enforcement: Promoting Competition and Innovation.

Feinstein DL, Kuhlmann P, Mucchetti PJ.

J Health Polit Policy Law. 2015 Aug;40(4):875-86. doi: 10.1215/03616878-3150112. Epub 2015 Jun 29.

PMID:
26124309
29.

Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning.

Ware KM, Feinstein DL, Rubinstein I, Weinberg G, Rovin BH, Hebert L, Muni N, Cianciolo RE, Satoskar AA, Nadasdy T, Brodsky SV.

Am J Nephrol. 2015;41(4-5):392-9. doi: 10.1159/000433568. Epub 2015 Jun 20.

30.

Cardiac depression induced by cocaine or cocaethylene is alleviated by lipid emulsion more effectively than by sulfobutylether-β-cyclodextrin.

Fettiplace MR, Pichurko A, Ripper R, Lin B, Kowal K, Lis K, Schwartz D, Feinstein DL, Rubinstein I, Weinberg G.

Acad Emerg Med. 2015 May;22(5):508-17. doi: 10.1111/acem.12657. Epub 2015 Apr 23.

31.

Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis.

Dupree JL, Polak PE, Hensley K, Pelligrino D, Feinstein DL.

J Neurochem. 2015 Jul;134(2):302-14. doi: 10.1111/jnc.13114. Epub 2015 Apr 22.

32.

Neuroinflammation in Alzheimer's disease.

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP.

Lancet Neurol. 2015 Apr;14(4):388-405. doi: 10.1016/S1474-4422(15)70016-5. Review.

33.

A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase B1, is a risk factor for multiple sclerosis.

Boullerne AI, Skias D, Hartman EM, Testai FD, Kalinin S, Polak PE, Feinstein DL.

ASN Neuro. 2015 Feb 18;7(1). pii: 1759091415568914. doi: 10.1177/1759091415568914. Print 2015 Jan-Feb.

34.

Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.

Braun D, Madrigal JL, Feinstein DL.

Curr Neuropharmacol. 2014 Jul;12(4):342-52. doi: 10.2174/1570159X12666140828220938.

35.

The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.

Polak PE, Lin SX, Pelligrino D, Feinstein DL.

J Neuroimmunol. 2014 Nov 15;276(1-2):135-41. doi: 10.1016/j.jneuroim.2014.09.004. Epub 2014 Sep 16.

PMID:
25242632
36.

Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.

Boullerne AI, Polak PE, Braun D, Sharp A, Pelligrino D, Feinstein DL.

J Neurochem. 2014 May;129(4):696-703. doi: 10.1111/jnc.12664. Epub 2014 Feb 13.

37.

Intraosseous lipid emulsion: an effective alternative to IV delivery in emergency situations.

Fettiplace MR, Ripper R, Lis K, Feinstein DL, Rubinstein I, Weinberg G.

Crit Care Med. 2014 Feb;42(2):e157-60. doi: 10.1097/01.ccm.0000435677.76058.15.

PMID:
24145832
38.

Dimethyl fumarate regulates histone deacetylase expression in astrocytes.

Kalinin S, Polak PE, Lin SX, Braun D, Guizzetti M, Zhang X, Rubinstein I, Feinstein DL.

J Neuroimmunol. 2013 Oct 15;263(1-2):13-9. doi: 10.1016/j.jneuroim.2013.07.007. Epub 2013 Aug 2.

PMID:
23916696
39.

Development of amyloid burden in African Green monkeys.

Kalinin S, Willard SL, Shively CA, Kaplan JR, Register TC, Jorgensen MJ, Polak PE, Rubinstein I, Feinstein DL.

Neurobiol Aging. 2013 Oct;34(10):2361-9. doi: 10.1016/j.neurobiolaging.2013.03.023. Epub 2013 Apr 18.

40.

IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis.

Hvaring C, Vujicic S, Aasly JO, Feinstein DL, White LR, Boullerne AI.

J Neuroimmunol. 2013 Mar 15;256(1-2):77-83. doi: 10.1016/j.jneuroim.2012.12.011. Epub 2013 Jan 22.

PMID:
23351705
41.

Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.

Polak PE, Dull RO, Kalinin S, Sharp AJ, Ripper R, Weinberg G, Schwartz DE, Rubinstein I, Feinstein DL.

J Neuroinflammation. 2012 Dec 19;9:272. doi: 10.1186/1742-2094-9-272.

42.

The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE.

Lisi L, McGuire S, Sharp A, Chiosis G, Navarra P, Feinstein DL, Dello Russo C.

J Neuroimmunol. 2013 Feb 15;255(1-2):1-7. doi: 10.1016/j.jneuroim.2012.10.008. Epub 2012 Nov 2.

43.

mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.

Dello Russo C, Lisi L, Feinstein DL, Navarra P.

Glia. 2013 Mar;61(3):301-11. doi: 10.1002/glia.22433. Epub 2012 Oct 8. Review.

PMID:
23044764
44.

Epinephrine induces rapid deterioration in pulmonary oxygen exchange in intact, anesthetized rats: a flow and pulmonary capillary pressure-dependent phenomenon.

Krishnamoorthy V, Hiller DB, Ripper R, Lin B, Vogel SM, Feinstein DL, Oswald S, Rothschild L, Hensel P, Rubinstein I, Minshall R, Weinberg GL.

Anesthesiology. 2012 Oct;117(4):745-54.

45.

Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease.

Colca JR, Feinstein DL.

Adv Pharmacol. 2012;64:155-76. doi: 10.1016/B978-0-12-394816-8.00005-2. Review.

PMID:
22840747
46.

The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.

Polak PE, Kalinin S, Braun D, Sharp A, Lin SX, Feinstein DL.

J Neurochem. 2012 Apr;121(2):206-16. doi: 10.1111/j.1471-4159.2012.07673.x. Epub 2012 Feb 17.

47.

Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis.

Lisi L, Navarra P, Cirocchi R, Sharp A, Stigliano E, Feinstein DL, Dello Russo C.

J Neuroimmunol. 2012 Feb 29;243(1-2):43-51. doi: 10.1016/j.jneuroim.2011.12.018. Epub 2012 Jan 20.

PMID:
22264993
48.

Beneficial effects of blueberries in experimental autoimmune encephalomyelitis.

Xin J, Feinstein DL, Hejna MJ, Lorens SA, McGuire SO.

J Agric Food Chem. 2012 Jun 13;60(23):5743-8. doi: 10.1021/jf203611t. Epub 2012 Feb 10.

PMID:
22243431
49.

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.

Kalinin S, Polak PE, Lin SX, Sakharkar AJ, Pandey SC, Feinstein DL.

Neurobiol Aging. 2012 Aug;33(8):1651-63. doi: 10.1016/j.neurobiolaging.2011.04.012. Epub 2011 Jun 25.

50.

Pioglitazone attenuates acute cocaine toxicity in rat isolated heart: potential protection by metabolic modulation.

Weinberg GL, Ripper R, Bern S, Lin B, Edelman L, Digregorio G, Piano M, Feinstein DL.

Anesthesiology. 2011 Jun;114(6):1389-95. doi: 10.1097/ALN.0b013e318218a7f6.

Supplemental Content

Loading ...
Support Center